FlowMedica Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.75M

FlowMedica General Information

Description

Developer of commercial-stage medical devices designed to offer targeted renal therapy for renal conditions associated with cardiovascular disease, cancer and surgery. The company's devices serve as an alternative to the standard delivery method of systemic intravenous (IV) infusion to address kidney dysfunction related to a number of conditions, including cardiovascular, endovascular, and surgical procedures and diseases, enabling surgeons to perform the infusion directly and with a careful measure.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 46563 Fremont Boulevard
  • Fremont, CA 94538
  • United States
Primary Industry
Other Devices and Supplies
Acquirer
Vertical(s)
Corporate Office
  • 46563 Fremont Boulevard
  • Fremont, CA 94538
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FlowMedica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 12-Jan-2009 $1.75M Completed Generating Revenue
4. Later Stage VC (Series D) 15-Nov-2005 Completed Generating Revenue
3. Later Stage VC (Series C) 19-Aug-2004 Completed Startup
2. Early Stage VC (Series B) Completed Startup
1. Early Stage VC (Series A) Completed Startup
To view FlowMedica’s complete valuation and funding history, request access »

FlowMedica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B2
Series B1
Series A2 1,411,764 $0.001000 $1 $1 1x $1 3.27%
Series A1 3,000,000 $0.001000 $1 $1 1x $1 6.95%
To view FlowMedica’s complete cap table history, request access »

FlowMedica Patents

FlowMedica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20090105799-A1 Renal assessment systems and methods Inactive 23-Oct-2007
WO-2009055564-A1 Renal assessment systems and methods Inactive 23-Oct-2007
WO-2008112563-A1 Acute kidney injury treatment systems and methods Inactive 09-Mar-2007
EP-2023997-A2 Selective renal cannulation and infusion systems and methods Inactive 08-Jun-2006
EP-2023997-A4 Selective renal cannulation and infusion systems and methods Inactive 08-Jun-2006 A61M25/0068
To view FlowMedica’s complete patent history, request access »

FlowMedica Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
ABN AMRO Bank Investment Bank Minority
De Novo Ventures Venture Capital Minority
Forbion Venture Capital Minority
Medica Venture Partners Venture Capital Minority
Mi3 Venture Partners Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

FlowMedica FAQs

  • When was FlowMedica founded?

    FlowMedica was founded in 2002.

  • Where is FlowMedica headquartered?

    FlowMedica is headquartered in Fremont, CA.

  • What industry is FlowMedica in?

    FlowMedica’s primary industry is Other Devices and Supplies.

  • Is FlowMedica a private or public company?

    FlowMedica is a Private company.

  • What is the current valuation of FlowMedica?

    The current valuation of FlowMedica is .

  • What is FlowMedica’s current revenue?

    The current revenue for FlowMedica is .

  • How much funding has FlowMedica raised over time?

    FlowMedica has raised $20.6M.

  • Who are FlowMedica’s investors?

    ABN AMRO Bank, De Novo Ventures, Forbion, Medica Venture Partners, and Mi3 Venture Partners are 5 of 9 investors who have invested in FlowMedica.

  • When was FlowMedica acquired?

    FlowMedica was acquired on 12-Jan-2009.

  • Who acquired FlowMedica?

    FlowMedica was acquired by Angiodynamics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process